Sulfation patterns in heparin and heparan sulfate: Effects on the proliferation of bovine pulmonary artery smooth muscle cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1639, Issue 3, 2003, Pages 225-231

  Garg, Hari G ^a   Yu, Lunyin ^a   Hales, Charles A ^a   Toida, Toshihiko ^b   Islam, Tasneem ^c   Linhardt, Robert J ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c E11 SSH   (United States)

^d RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

1H NMR; Heparan sulfate; Heparin; Post column derivatization HPLC; Proliferation; Smooth muscle cell

Indexed keywords

ACETIC ACID DERIVATIVE; HEPARAN SULFATE; HEPARIN; HEXOSAMINE; SULFONIC ACID DERIVATIVE; URONIC ACID;

ACETYLATION; ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CATTLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG SULFATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SMOOTH MUSCLE FIBER; SUBSTITUTION REACTION;

BOVINAE; SUIDAE;

EID: 0242493091     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.09.002     Document Type: Article

References (22)

1. Hascall V.C., Heinegard D.K., Wright D.K. Proteoglycans: metabolism and pathology. Hay E.B. Cell Biology of Extracellular Matrix. 1991;1023-1030 Plenum, New York.
2. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
3. Casu B. Structure of heparin and heparin fragments. Ann. N.Y. Acad. Sci. 556:1989;1-17.
4. Garg H.G., Lyon N.C. Structure of collagen fibril-associated small proteoglycans of mammalian origin. Adv. Carbohydr. Chem. Biochem. 49:1991;239-261.
5. Garg H.G., Joseph P.M., Thompson B.T., Hales C.A., Toida T., Imanari T., Capila I., Linhardt R.J. Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation. Arch. Biochem. Biophys. 371:1999;228-233.
6. Tiozzo R., Cingi M.R., Reggiani D., Andreoli T., Calandra S., Milani M.R., Piani S., Marchi E., Barbanti M. Effect of desulfation of heparin on its anticoagulant and antiproliferative activity. Thromb. Res. 70:1993;99-106.
7. + exchange and growth of PASMC. Am. J. Physiol. 270:1996;L260-L265.
8. Garg H.G., Joseph P.A.M., Yoshida K., Thompson B.T., Hales C.A. Antiproliferative role of 3-O-sulfate glucosamine in heparin on cultured pulmonary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 224:1996;468-473.
9. Joseph P.A.M., Garg H.G., Thompson B.T., Liu X., Hales C.A. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 241:1997;18-23.
10. Toida T., Kakinuma N., Toyoda H., Imanari T. 1H-NMR profile of glycosaminoglycans in human urine. Anal. Sci. 10:1994;537-541.
11. Linhardt R.J. Analysis of glycosaminoglycans with polysaccharide lyases. Varki A. Current Protocols in Molecular Biology. 1994;17.13.17-17.13.32 Wiley Interscience, New York, NY.
12. Nagasawa K., Uchiyama H., Wajima N. Chemical sulfation of preparations of chondroitin 4- and 6-sulfate, and dermatan sulfate. Preparation of chondroitin sulfate E-like materials from chondroitin 4-sulfate. Carbohydr. Res. 158:1986;183-190.
13. Levy L., Petracek F.J. Chemical and pharmacological studies on N-resulfated heparin. Proc. Soc. Exp. Biol. Med. 109:1962;901-905.
14. Sudo M., Sato K., Chaidedgumjorn A., Toyoda H., Toida T., Imanari T. (1) H NMR analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate. Anal. Biochem. 297:2001;42-51.
15. Matsuo M., Takano R., Kamei-Hayashi K., Hara S. A novel regioselective desulfation of polysaccharide sulfates: specific 6-O-desulfation with N,O-bis(trimethylsilyl)acetamide. Carbohydr. Res. 241:1993;209-215.
16. Garg H.G., Hales C.A., Linhardt R.J. Heparin as a potential therapeutic agent to reverse vascular remodeling. Garg H.G., Roughley P.J., Hales C.A. Proteoglycans in Lung Disease. 2002;377-398 Marcel Dekker, New York, NY.
17. Gehring H., Schroder A. Thymidine secretion by cultured chicken embryo fibroblasts and NIH/3T3 cells: quantification and time course. Biochem. Biophys. Res. Commun. 177:1991;259-264.
18. Jarvelainen H., Wight T.N. Vascular proteoglycans. Garg H.G., Roughley P.J., Hales C.A. Proteoglycans in Lung Disease. 2003;291-321 Marcel Dekker, New York, NY.
19. Benitz W.E., Bernfield M. Endothelial cell proteoglycans: possible mediators of vascular responses to injury. Am. J. Respir. Cell Mol. Biol. 2:1990;407-408.
20. Castellot J.J. Jr., Beeler D.L., Rosenberg R.D., Karnovsky M.J. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. J. Cell. Physiol. 120:1984;315-320.
21. Castellot J.J. Jr., Choay J., Lormeau J.C., Petitou M., Sache E., Karnovsky M.J. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells: II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group. J. Cell Biol. 102:1986;1979-1984.
22. Longas M.O., Garg H.G., Trinkle-Pereira J.M., Hales C.A. Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells require both N-acetylation and N-sulfonation. Carbohydr. Res. 338:2003;251-256.